CA Stock MarketDetailed Quotes

NSHS Nanosphere Health Sciences Inc

Watchlist
  • 0.035
  • 0.0000.00%
15min DelayPost-Market Auction Session Nov 25 09:30 ET
359.63KMarket Cap-1296P/E (TTM)

Nanosphere Health Sciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-13.39%22.68K
-75.81%8.13K
-83.07%9.32K
-83.07%9.32K
-81.29%11.37K
-70.39%26.19K
-73.00%33.6K
-57.93%55.01K
-57.93%55.01K
-59.20%60.75K
-Cash and cash equivalents
-13.39%22.68K
-75.81%8.13K
-83.07%9.32K
-83.07%9.32K
-81.29%11.37K
-70.39%26.19K
-73.00%33.6K
-57.93%55.01K
-57.93%55.01K
-59.20%60.75K
Receivables
44.56%10.32K
75.43%9.8K
71.81%8.66K
71.81%8.66K
82.15%7.65K
83.83%7.14K
122.56%5.58K
186.74%5.04K
186.74%5.04K
104.43%4.2K
-Accounts receivable
44.56%10.32K
75.43%9.8K
71.81%8.66K
71.81%8.66K
82.15%7.65K
83.83%7.14K
122.56%5.58K
186.74%5.04K
186.74%5.04K
--4.2K
Total current assets
-0.98%33K
-54.26%17.92K
-70.07%17.97K
-70.07%17.97K
-70.71%19.02K
-64.37%33.33K
-69.92%39.18K
-54.68%60.05K
-54.68%60.05K
-56.97%64.95K
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-0.98%33K
-54.26%17.92K
-70.07%17.97K
-70.07%17.97K
-70.71%19.02K
-64.37%33.33K
-69.92%39.18K
-54.68%60.05K
-54.68%60.05K
-56.97%64.95K
Liabilities
Current liabilities
Current debt and capital lease obligation
--30.75K
----
----
----
----
----
----
----
----
----
-Current debt
--30.75K
----
----
----
----
----
----
----
----
----
Current liabilities
11.49%1.66M
13.62%1.6M
14.76%1.57M
14.76%1.57M
17.39%1.5M
14.03%1.49M
9.76%1.4M
13.57%1.37M
13.57%1.37M
10.36%1.28M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
11.49%1.66M
13.62%1.6M
14.76%1.57M
14.76%1.57M
17.39%1.5M
14.03%1.49M
9.76%1.4M
13.57%1.37M
13.57%1.37M
10.36%1.28M
Shareholders'equity
Share capital
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
-1.27%18.76M
-common stock
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
0.00%18.76M
-1.27%18.76M
Retained earnings
-0.93%-21.65M
-1.01%-21.59M
-1.07%-21.55M
-1.07%-21.55M
-1.26%-21.49M
-1.23%-21.45M
-1.26%-21.37M
-1.34%-21.32M
-1.34%-21.32M
-0.00%-21.23M
Gains losses not affecting retained earnings
2.20%1.26M
0.27%1.25M
-1.32%1.23M
-1.32%1.23M
-0.13%1.25M
1.38%1.23M
4.14%1.25M
3.78%1.24M
3.78%1.24M
2.91%1.25M
Total stockholders'equity
-11.78%-1.63M
-15.57%-1.58M
-18.64%-1.56M
-18.64%-1.56M
-22.10%-1.48M
-20.07%-1.46M
-18.79%-1.36M
-21.98%-1.31M
-21.98%-1.31M
-20.45%-1.21M
Total equity
-11.78%-1.63M
-15.57%-1.58M
-18.64%-1.56M
-18.64%-1.56M
-22.10%-1.48M
-20.07%-1.46M
-18.79%-1.36M
-21.98%-1.31M
-21.98%-1.31M
-20.45%-1.21M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -13.39%22.68K-75.81%8.13K-83.07%9.32K-83.07%9.32K-81.29%11.37K-70.39%26.19K-73.00%33.6K-57.93%55.01K-57.93%55.01K-59.20%60.75K
-Cash and cash equivalents -13.39%22.68K-75.81%8.13K-83.07%9.32K-83.07%9.32K-81.29%11.37K-70.39%26.19K-73.00%33.6K-57.93%55.01K-57.93%55.01K-59.20%60.75K
Receivables 44.56%10.32K75.43%9.8K71.81%8.66K71.81%8.66K82.15%7.65K83.83%7.14K122.56%5.58K186.74%5.04K186.74%5.04K104.43%4.2K
-Accounts receivable 44.56%10.32K75.43%9.8K71.81%8.66K71.81%8.66K82.15%7.65K83.83%7.14K122.56%5.58K186.74%5.04K186.74%5.04K--4.2K
Total current assets -0.98%33K-54.26%17.92K-70.07%17.97K-70.07%17.97K-70.71%19.02K-64.37%33.33K-69.92%39.18K-54.68%60.05K-54.68%60.05K-56.97%64.95K
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -0.98%33K-54.26%17.92K-70.07%17.97K-70.07%17.97K-70.71%19.02K-64.37%33.33K-69.92%39.18K-54.68%60.05K-54.68%60.05K-56.97%64.95K
Liabilities
Current liabilities
Current debt and capital lease obligation --30.75K------------------------------------
-Current debt --30.75K------------------------------------
Current liabilities 11.49%1.66M13.62%1.6M14.76%1.57M14.76%1.57M17.39%1.5M14.03%1.49M9.76%1.4M13.57%1.37M13.57%1.37M10.36%1.28M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 11.49%1.66M13.62%1.6M14.76%1.57M14.76%1.57M17.39%1.5M14.03%1.49M9.76%1.4M13.57%1.37M13.57%1.37M10.36%1.28M
Shareholders'equity
Share capital 0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M-1.27%18.76M
-common stock 0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M0.00%18.76M-1.27%18.76M
Retained earnings -0.93%-21.65M-1.01%-21.59M-1.07%-21.55M-1.07%-21.55M-1.26%-21.49M-1.23%-21.45M-1.26%-21.37M-1.34%-21.32M-1.34%-21.32M-0.00%-21.23M
Gains losses not affecting retained earnings 2.20%1.26M0.27%1.25M-1.32%1.23M-1.32%1.23M-0.13%1.25M1.38%1.23M4.14%1.25M3.78%1.24M3.78%1.24M2.91%1.25M
Total stockholders'equity -11.78%-1.63M-15.57%-1.58M-18.64%-1.56M-18.64%-1.56M-22.10%-1.48M-20.07%-1.46M-18.79%-1.36M-21.98%-1.31M-21.98%-1.31M-20.45%-1.21M
Total equity -11.78%-1.63M-15.57%-1.58M-18.64%-1.56M-18.64%-1.56M-22.10%-1.48M-20.07%-1.46M-18.79%-1.36M-21.98%-1.31M-21.98%-1.31M-20.45%-1.21M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data